FOCUS-Patient groups push back against Gilead’s pricey HIV prevention treatment
Gilead Sciences Inc
hopes to soon introduce a pricey new pill to prevent HIV in
people at risk of contracting the infection, but the drugmaker
faces opposition from an unusual source: patient advocates.
hopes to soon introduce a pricey new pill to prevent HIV in
people at risk of contracting the infection, but the drugmaker
faces opposition from an unusual source: patient advocates.
Posted by Reuters